Type 2 Diabetes Trial, Recruiting NCT06382480 Sponsor: German Institute of Human Nutrition Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT06382480
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have prediabetes, meaning a fasting blood sugar level between 100–125 mg/dl
  • People who have type 2 diabetes, meaning a fasting blood sugar level above 126 mg/dl
  • People who are overweight or obese, with a BMI between 25 and 50 kg/m²

Who may not be able to join:

  • People who have a type of diabetes other than type 2
  • People who are currently using insulin treatment
  • People who work shift work
  • People whose weight has changed by more than 5% in the past 3 months
  • People who are taking steroid (glucocorticoid) medications that affect the whole body
  • People who have an active widespread infection in the body
  • People who have severe anaemia (very low red blood cell levels)
  • People who have high blood pressure above 180/110 mmHg
  • People who have hormone gland, liver, or heart conditions
  • People who have immune system diseases
  • People who have a thyroid condition
  • People who have previously had a heart attack or stroke
  • People who have had cancer within the last 2 years
  • People who have an eating disorder, food intolerance or allergy, addiction disorder, or digestive, intestinal, liver, or cardiovascular disease
  • People who have a blood clotting disorder, whether inherited or acquired
  • People who cannot stop taking blood-thinning (anticoagulant) medications
  • People who are currently following a specific diet plan or practising intermittent fasting
  • People who are pregnant or breastfeeding
  • People who have a severe internal or psychiatric condition, or who are taking medications that might affect the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olga Ramich, PD Dr., German Institute of Human Nutrition

Phone: +4933200882749

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
German Institute of Human Nutrition
Registry
ClinicalTrials.gov
Start date
12 April 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Mean 24-hour glucose

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov